Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Signe Düring

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|March 16, 2011
[Recurrence following discontinuation of 28 years of lithium therapy]Signe Düring Wegmann, Lars Vedel Kessing
The International Journal of Neuropsychopharmacology|October 11, 2015
Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia PatientsSigne Düring, Birte Yding Glenthøj, Bob Oranje
Danish Medical Journal|July 12, 2016
Male circumcision does not result in inferior perceived male sexual function - a systematic reviewDaniel Mønsted Shabanzadeh, Signe Düring, Cai Frimodt-Møller
Bulletin of the History of Medicine|November 25, 2024
Patients' Views on Psychiatry, Coercion, and Social ClassSigne Düring, Sarah Kirkegaard Jensen, Line Keller Jensen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 24, 2014
Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patientsSigne Düring, Birte Y Glenthøj, Gitte Saltoft Andersen, et al.
Basic & Clinical Pharmacology & Toxicology|June 12, 2026
The Imperative of Involving Nurses When Reviewing Psychiatric Medication: a Qualitative Study of Implementing Physician-Led Medication Reviews for Psychiatric Outpatients With DiabetesJohan Frederik Mebus Meyer Christensen, Elisabeth Mebus Meyer Christensen, Ulla Christensen, et al.
Psychological Medicine|June 20, 2018
Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patientsCaitlyn Kruiper, Birgitte Fagerlund, Mette Ø Nielsen, et al.
JAMA Psychiatry|September 3, 2025
Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity: The HISTORI Randomized Clinical TrialAshok A Ganeshalingam, Nicolai Uhrenholt, Sidse Arnfred, et al.
Pilot and Feasibility Studies|May 16, 2024
The LIVER CARE trial - screening for liver disease in individuals attending treatment for alcohol use disorder: a randomized controlled feasibility trialPeter Jepsen, Natasja von Wowern, Lone Galmstrup Madsen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|March 16, 2011
[Recurrence following discontinuation of 28 years of lithium therapy]Signe Düring Wegmann, Lars Vedel Kessing
The International Journal of Neuropsychopharmacology|October 11, 2015
Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia PatientsSigne Düring, Birte Yding Glenthøj, Bob Oranje
Danish Medical Journal|July 12, 2016
Male circumcision does not result in inferior perceived male sexual function - a systematic reviewDaniel Mønsted Shabanzadeh, Signe Düring, Cai Frimodt-Møller
Bulletin of the History of Medicine|November 25, 2024
Patients' Views on Psychiatry, Coercion, and Social ClassSigne Düring, Sarah Kirkegaard Jensen, Line Keller Jensen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 24, 2014
Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patientsSigne Düring, Birte Y Glenthøj, Gitte Saltoft Andersen, et al.
Basic & Clinical Pharmacology & Toxicology|June 12, 2026
The Imperative of Involving Nurses When Reviewing Psychiatric Medication: a Qualitative Study of Implementing Physician-Led Medication Reviews for Psychiatric Outpatients With DiabetesJohan Frederik Mebus Meyer Christensen, Elisabeth Mebus Meyer Christensen, Ulla Christensen, et al.
Psychological Medicine|June 20, 2018
Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patientsCaitlyn Kruiper, Birgitte Fagerlund, Mette Ø Nielsen, et al.
JAMA Psychiatry|September 3, 2025
Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity: The HISTORI Randomized Clinical TrialAshok A Ganeshalingam, Nicolai Uhrenholt, Sidse Arnfred, et al.
Pilot and Feasibility Studies|May 16, 2024
The LIVER CARE trial - screening for liver disease in individuals attending treatment for alcohol use disorder: a randomized controlled feasibility trialPeter Jepsen, Natasja von Wowern, Lone Galmstrup Madsen, et al.
Pageof 1